877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Polycyclic organic compounds, Heterocyclic compound, Atypical antipsychotics, Dopamine antagonists, Piperazines

Categories

Antidepressants (1)
Antipsychotics (1)
Cyclic compounds (1)
Drugs acting on the nervous system (1)
Heterocyclic compounds (1)
Heterocyclic compounds (bridged-ring) (1)
Mood stabilizers (1)
Pharmaceuticals (1)
Psychoactive drugs (1)
Psychoanaleptics (1)
Psychopharmacology (1)
Six-membered rings (1)

Suppliers

AK Scientific (1)
Oakwood Chemical (1)

Lurasidone (367514-88-3, 367514-87-2)  
Lurasidone (trade name Latuda) is an atypical antipsychotic developed by Dainippon Sumitomo Pharma and marketed by Sunovion in the U.S. It has been an FDA approved treatment for schizophrenia since 2010 and for treating depressive episodes in adults with bipolar I disorder since 2013. It can be used alone or in combination with mood stabilizers such as lithium or valproate (e.g., Depakote).
Related searches
Polycyclic organic compounds
Heterocyclic compound
Atypical antipsychotics
Dopamine antagonists
Piperazines